CFI-402411

· Treadwell Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CFI-402411, covering 2025-05-21 to 2025-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of CFI-402411 in Subjects With Advanced Solid Malignancies [Phase 1, Phase 2]